Skip to main content
Signal8

Dere Willard H

SEC insider (Form 3/4/5 filer). CIK 0001311569. Director at Seres Therapeutics, Inc. (MCRB) and 3 other issuers. 20 reported Form 4/5 transactions since Sep 2024; latest on Jul 8, 2026. Located in CAMBRIDGE, MA.

Companies Dere Willard H has filed insider reports for

  • Seres Therapeutics, Inc. (MCRB): Director
  • Metagenomi Therapeutics, Inc. (MGX): Director
  • BIOMARIN PHARMACEUTICAL INC (BMRN): Director
  • Mersana Therapeutics, Inc. (MRSN): Director
Dere Willard H profile photo

Dere Willard H

CIK: 0001311569

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (35.0%)

Compensation grants

Other (G, F, J, C, D, …)13 (65.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (4)

Seres Therapeutics, Inc. logo
MCRB

Seres Therapeutics, Inc.

Director
Metagenomi Therapeutics, Inc. logo
MGX

Metagenomi Therapeutics, Inc.

Director
BIOMARIN PHARMACEUTICAL INC logo
BMRN

BIOMARIN PHARMACEUTICAL INC

Director
Mersana Therapeutics, Inc. logo
MRSN

Mersana Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • Seres Therapeutics, Inc. logo
    MCRB

    Seres Therapeutics, Inc.

    Jul 8, 2026
    Award

    Stock Option (right to buy)

    Direct
    6.5K shares-
  • Metagenomi Therapeutics, Inc. logo
    MGX

    Metagenomi Therapeutics, Inc.

    Jun 9, 2026
    Award

    Stock Option (Right to Buy)

    Direct
    21K shares-
  • BIOMARIN PHARMACEUTICAL INC logo
    BMRN

    BIOMARIN PHARMACEUTICAL INC

    Jun 2, 2026
    Award
    Direct
    7.5K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    2.5K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    800 shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    544 shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    1K shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    450 shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    368 shares-
  • Mersana Therapeutics, Inc. logo
    MRSN

    Mersana Therapeutics, Inc.

    Jan 6, 2026
    Disposition

    Stock Option (right to buy)

    Direct
    125 shares-

1-10 of 20